Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases.

Tyagi S, Gupta P, Saini AS, Kaushal C, Sharma S.

J Adv Pharm Technol Res. 2011 Oct;2(4):236-40. doi: 10.4103/2231-4040.90879.

2.

PPAR dual agonists: are they opening Pandora's Box?

Balakumar P, Rose M, Ganti SS, Krishan P, Singh M.

Pharmacol Res. 2007 Aug;56(2):91-8. Epub 2007 Mar 14. Review.

PMID:
17428674
3.

Peroxisome proliferator-activated receptor (PPAR)β/δ, a possible nexus of PPARα- and PPARγ-dependent molecular pathways in neurodegenerative diseases: Review and novel hypotheses.

Aleshin S, Strokin M, Sergeeva M, Reiser G.

Neurochem Int. 2013 Oct;63(4):322-30. doi: 10.1016/j.neuint.2013.06.012. Epub 2013 Jun 25. Review.

PMID:
23811400
4.

Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels.

Yessoufou A, Wahli W.

Swiss Med Wkly. 2010 Sep 15;140:w13071. doi: 10.4414/smw.2010.13071. Review.

5.
7.

Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.

Marx N, Duez H, Fruchart JC, Staels B.

Circ Res. 2004 May 14;94(9):1168-78. Review.

8.

Peroxisome proliferator-activated receptors: from genes to physiology.

Kliewer SA, Xu HE, Lambert MH, Willson TM.

Recent Prog Horm Res. 2001;56:239-63. Review.

PMID:
11237216
9.

The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation.

Schoonjans K, Staels B, Auwerx J.

Biochim Biophys Acta. 1996 Jul 26;1302(2):93-109. Review.

PMID:
8695669
10.

Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism.

Gilde AJ, van der Lee KA, Willemsen PH, Chinetti G, van der Leij FR, van der Vusse GJ, Staels B, van Bilsen M.

Circ Res. 2003 Mar 21;92(5):518-24. Epub 2003 Feb 6.

11.

Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.

Touyz RM, Schiffrin EL.

Vascul Pharmacol. 2006 Jul;45(1):19-28. Epub 2006 Jun 16. Review.

PMID:
16782410
13.

[PPAR receptors: recent data].

Vidal H.

Ann Endocrinol (Paris). 2005 Apr;66(2 Pt 2):1S5-9. Review. French.

PMID:
15959399
14.
15.

Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases.

Monsalve FA, Pyarasani RD, Delgado-Lopez F, Moore-Carrasco R.

Mediators Inflamm. 2013;2013:549627. doi: 10.1155/2013/549627. Epub 2013 May 27. Review.

16.

Peroxisome proliferator-activated receptor beta/delta as a therapeutic target for metabolic diseases.

Bedu E, Wahli W, Desvergne B.

Expert Opin Ther Targets. 2005 Aug;9(4):861-73. Review.

PMID:
16083348
17.

Peroxisome proliferator-activated receptors and the control of inflammation.

Cabrero A, Laguna JC, Vázquez M.

Curr Drug Targets Inflamm Allergy. 2002 Sep;1(3):243-8. Review.

PMID:
14561188
18.

Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes.

Blaschke F, Takata Y, Caglayan E, Law RE, Hsueh WA.

Arterioscler Thromb Vasc Biol. 2006 Jan;26(1):28-40. Epub 2005 Oct 20. Review.

19.

Peroxisome proliferator-activated receptors and inflammation.

Moraes LA, Piqueras L, Bishop-Bailey D.

Pharmacol Ther. 2006 Jun;110(3):371-85. Epub 2005 Sep 15. Review.

PMID:
16168490
20.

[Pathophysiological relevance of peroxisome proliferators activated receptors (PPAR) to joint diseases - the pro and con of agonists].

Jouzeau JY, Moulin D, Koufany M, Sebillaud S, Bianchi A, Netter P.

J Soc Biol. 2008;202(4):289-312. doi: 10.1051/jbio:2008034. Epub 2008 Dec 19. Review. French.

PMID:
19094928
Items per page

Supplemental Content

Write to the Help Desk